Previous studies addressed that the inhibition of FDFT1 significantly inhibited prostate cancer cell proliferation, reflecting the antitumor effects in prostate cancer development and its aggressive phenotypes by suppression of FDFT1 expression.22 This evidence concerns the gene FDFT1 and prostate carcinoma.